Update in pathological classification of cervical intraepithelial neoplasia and cervical cancer

Meenakshi Swain
{"title":"Update in pathological classification of cervical intraepithelial neoplasia and cervical cancer","authors":"Meenakshi Swain","doi":"10.4103/jclgtp.jclgtp_17_23","DOIUrl":null,"url":null,"abstract":"Cervical cancer is the second most common cancer in Indian women and the second leading cause of death, accounting for up to 29% of all malignancies. Human papillomavirus (HPV) is now established as the causative agent of most cervical squamous cell carcinomas (SCCs) and a large majority of adenocarcinomas, except a few HPV-independent subtypes. Both squamous and glandular lesions have precursor lesions called squamous intraepithelial lesions (SILs) and adenocarcinoma in situ (AIS), respectively. The term SIL replaces the earlier cervical intraepithelial neoplasia (CIN), in both cytology and histology specimens. The three-tier classification of CIN1, CIN2 and CIN3 is now a two-tier system, namely low grade SIL (LSIL) and high grade SIL (HSIL). HSIL may further be classified as HSIL CIN2 / HSIL CIN3 as applicable, since HSIL CIN2 has a higher rate of regression, especially in younger women. HPV-independent SIL and SCC are almost nonexistent. In contrast, AIS and adenocarcinoma have established HPV-independent types, many with an aggressive behavior and a worse prognosis. HPV-independent adenocarcinomas have gastric, clear cell, mesonephric and endometrioid types. Certain morphologic features and demonstration of HPV by immunohistochemistry (IHC) for p16, a good surrogate marker for HPV, are among the essential and desirable criteria outlined by the fifth edition of the World Health Organization published in 2020, for diagnosis of the HPV-associated cervical carcinomas. High-risk HPV testing can also be done by molecular techniques such as DNA and mRNA in situ hybridization. These methods are not widely available and are expensive; hence, IHC is a good alternative.","PeriodicalId":476164,"journal":{"name":"Journal of Colposcopy and Lower Genital Tract Pathology","volume":"17 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Colposcopy and Lower Genital Tract Pathology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/jclgtp.jclgtp_17_23","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Cervical cancer is the second most common cancer in Indian women and the second leading cause of death, accounting for up to 29% of all malignancies. Human papillomavirus (HPV) is now established as the causative agent of most cervical squamous cell carcinomas (SCCs) and a large majority of adenocarcinomas, except a few HPV-independent subtypes. Both squamous and glandular lesions have precursor lesions called squamous intraepithelial lesions (SILs) and adenocarcinoma in situ (AIS), respectively. The term SIL replaces the earlier cervical intraepithelial neoplasia (CIN), in both cytology and histology specimens. The three-tier classification of CIN1, CIN2 and CIN3 is now a two-tier system, namely low grade SIL (LSIL) and high grade SIL (HSIL). HSIL may further be classified as HSIL CIN2 / HSIL CIN3 as applicable, since HSIL CIN2 has a higher rate of regression, especially in younger women. HPV-independent SIL and SCC are almost nonexistent. In contrast, AIS and adenocarcinoma have established HPV-independent types, many with an aggressive behavior and a worse prognosis. HPV-independent adenocarcinomas have gastric, clear cell, mesonephric and endometrioid types. Certain morphologic features and demonstration of HPV by immunohistochemistry (IHC) for p16, a good surrogate marker for HPV, are among the essential and desirable criteria outlined by the fifth edition of the World Health Organization published in 2020, for diagnosis of the HPV-associated cervical carcinomas. High-risk HPV testing can also be done by molecular techniques such as DNA and mRNA in situ hybridization. These methods are not widely available and are expensive; hence, IHC is a good alternative.
宫颈上皮内瘤变和宫颈癌病理分类的最新进展
子宫颈癌是印度妇女第二大常见癌症,也是第二大死亡原因,占所有恶性肿瘤的29%。人类乳头瘤病毒(HPV)现在被确定为大多数宫颈鳞状细胞癌(SCCs)和绝大多数腺癌的病原体,除了少数HPV独立亚型。鳞状和腺状病变都有前体病变,分别称为鳞状上皮内病变(SILs)和原位腺癌(AIS)。在细胞学和组织学标本中,术语SIL取代了早期的宫颈上皮内瘤变(CIN)。CIN1、CIN2和CIN3的三层分类现在是两层系统,即低等级SIL (LSIL)和高等级SIL (HSIL)。由于HSIL CIN2具有较高的退行率,尤其在年轻女性中,如果适用,HSIL可进一步分类为HSIL CIN2 / HSIL CIN3。与hpv无关的SIL和SCC几乎不存在。相比之下,AIS和腺癌已经建立了与hpv无关的类型,许多具有侵袭性行为和较差的预后。不依赖hpv的腺癌有胃癌、透明细胞癌、肾小球癌和子宫内膜癌。p16是HPV的一种很好的替代标志物,免疫组织化学(IHC)对HPV的某些形态特征和证明是2020年出版的世界卫生组织第五版中概述的用于HPV相关宫颈癌诊断的基本和理想标准之一。高危HPV检测也可以通过DNA和mRNA原位杂交等分子技术来完成。这些方法不能广泛使用,而且价格昂贵;因此,免疫组化是一个很好的选择。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书